Ethyl glucuronide (EtG) is a direct biomarker of alcohol consumption detectable in urine. An estimation tool utilizes EtG concentrations in urine to provide an approximate timeframe of alcohol use. These applications often incorporate factors such as urine creatinine levels and fluid intake to refine the assessment, offering an aid in interpreting test results. As an example, inputting a specific EtG level and creatinine value into such a resource might yield an estimated timeframe within which alcohol consumption occurred.
These estimation resources offer potential benefits in various settings, including clinical monitoring of abstinence, workplace drug testing programs, and legal contexts such as probation or child custody cases. They provide a more nuanced understanding of alcohol consumption patterns compared to simple positive or negative results. Historically, the development of EtG testing, combined with analytical tools, represents a significant advancement in alcohol detection, moving beyond traditional methods that only measured the presence of alcohol itself, which is rapidly metabolized.
